The capacity to generate therapeutically relevant cell types requires precise control of signaling pathways and gene networks needed to direct cells into function derivatives. We use developmental biology to inform our protocol design to guide cells into cardiac and vascular subtypes with high purity.

Project members

Key contacts

Dr Nathan Palpant

Group Leader, Genomics of Development and Disease Division
Senior Research Fellow - GL
Institute for Molecular Bioscience